- Home
- ATRA vs SWZ Comparison
ATRA vs SWZ Comparison
Compare ATRA & SWZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATRA | SWZ |
|---|---|---|
| Founded | 2012 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.2M | 77.3M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATRA | SWZ |
|---|---|---|
| Price | $9.00 | $6.00 |
| Analyst Decision | Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 44.7K | 23.2K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.59% |
| EPS Growth | ★ 122.52 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $120,772,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.92 | $5.84 |
| 52 Week High | $19.15 | $6.31 |
Technical Indicators
Market Signals| Indicator | ATRA | SWZ |
|---|---|---|
| Relative Strength Index (RSI) | 51.47 | 65.92 |
| Support Level | $9.03 | $5.91 |
| Resistance Level | $11.17 | $6.11 |
| Average True Range (ATR) | 0.66 | 0.04 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 62.01 | 86.96 |
Price Performance
Historical ComparisonAbout ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
About SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. It actively manages investment solutions spanning public and private markets, wealth management, and Solutions.